Portfolio

  1. TOP
  2. Portfolio
  3. miRagen Therapeutics, Inc.

miRagen Therapeutics, Inc.

miRagen Therapeutics, Inc.

M&A

Category Healthcare / Biotech
Business Line Development of nuclid acid therapeutics targeting microRNAs
URL http://miragentherapeutics.com/
President William S. Marshall, Ph.D.
Establishment July 2007
Initial Investment October 2015